Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1678 (LINC01678) is a long intergenic non-coding RNA (lincRNA), defined as an RNA molecule longer than 200 nucleotides that does not encode a protein and does not overlap with protein-coding genes[1][3][7]. lincRNAs, as a class, can regulate gene expression at transcriptional and epigenetic levels, modulate the activity of transcription factors and chromatin regulators, and contribute to the regulation of cellular processes such as the cell cycle, proliferation, and differentiation[3][7]. However, there is currently no published information detailing any therapeutic targeting, interacting drugs, or specific molecular or disease roles for LINC01678[1]. It is identified in genomic databases as a non-protein-coding RNA locus, and its precise biological function remains to be experimentally determined[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1678 (LINC01678).